Annual Current Assets
$347.29 M
+$61.53 M+21.53%
31 December 2023
Summary:
Keros Therapeutics annual total current assets is currently $347.29 million, with the most recent change of +$61.53 million (+21.53%) on 31 December 2023. During the last 3 years, it has risen by +$79.57 million (+29.72%). KROS annual current assets is now at all-time high.KROS Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$552.05 M
+$119.33 M+27.58%
30 September 2024
Summary:
Keros Therapeutics quarterly total current assets is currently $552.05 million, with the most recent change of +$119.33 million (+27.58%) on 30 September 2024. Over the past year, it has increased by +$247.61 million (+81.33%). KROS quarterly current assets is now at all-time high.KROS Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.5% | +81.3% |
| 3 y3 years | +29.7% | +144.2% |
| 5 y5 years | +1260.3% | - |
KROS Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +38.1% | at high | +148.3% |
| 5 y | 5 years | at high | +3790.4% | at high | +6084.0% |
| alltime | all time | at high | +3790.4% | at high | +6084.0% |
Keros Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $552.05 M(+27.6%) |
| June 2024 | - | $432.71 M(-6.6%) |
| Mar 2024 | - | $463.13 M(+33.4%) |
| Dec 2023 | $22.73 M(+8.2%) | $347.29 M(+14.1%) |
| Sept 2023 | - | $304.44 M(-8.9%) |
| June 2023 | - | $334.31 M(-7.7%) |
| Mar 2023 | - | $362.22 M(+26.8%) |
| Dec 2022 | $21.01 M | $285.77 M(+16.2%) |
| Sept 2022 | - | $245.88 M(+10.6%) |
| June 2022 | - | $222.36 M(-3.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $231.22 M(-8.0%) |
| Dec 2021 | $3.81 M(+122.0%) | $251.44 M(+11.2%) |
| Sept 2021 | - | $226.07 M(-6.4%) |
| June 2021 | - | $241.42 M(-5.7%) |
| Mar 2021 | - | $255.98 M(-4.4%) |
| Dec 2020 | $1.72 M(-15.3%) | $267.73 M(+96.3%) |
| Sept 2020 | - | $136.42 M(-8.1%) |
| June 2020 | - | $148.52 M(+153.7%) |
| Mar 2020 | - | $58.54 M(+555.8%) |
| Dec 2019 | $2.03 M(+7.8%) | $8.93 M |
| Dec 2018 | $1.88 M | - |
FAQ
- What is Keros Therapeutics annual total current assets?
- What is the all time high annual current assets for Keros Therapeutics?
- What is Keros Therapeutics annual current assets year-on-year change?
- What is Keros Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Keros Therapeutics?
- What is Keros Therapeutics quarterly current assets year-on-year change?
What is Keros Therapeutics annual total current assets?
The current annual current assets of KROS is $347.29 M
What is the all time high annual current assets for Keros Therapeutics?
Keros Therapeutics all-time high annual total current assets is $347.29 M
What is Keros Therapeutics annual current assets year-on-year change?
Over the past year, KROS annual total current assets has changed by +$61.53 M (+21.53%)
What is Keros Therapeutics quarterly total current assets?
The current quarterly current assets of KROS is $552.05 M
What is the all time high quarterly current assets for Keros Therapeutics?
Keros Therapeutics all-time high quarterly total current assets is $552.05 M
What is Keros Therapeutics quarterly current assets year-on-year change?
Over the past year, KROS quarterly total current assets has changed by +$247.61 M (+81.33%)